Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.80)
# 3,353
Out of 5,139 analysts
76
Total ratings
35.56%
Success rate
-8.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Initiates: Overweight | $30 | $16.39 | +83.04% | 1 | Jan 9, 2026 | |
| HNGE Hinge Health | Initiates: Overweight | $68 | $43.33 | +56.94% | 1 | Jan 9, 2026 | |
| WAY Waystar Holding | Initiates: Overweight | $41 | $30.27 | +35.45% | 1 | Jan 9, 2026 | |
| CTEV Claritev | Initiates: Equal-Weight | $33 | $30.44 | +8.41% | 1 | Jan 9, 2026 | |
| OMDA Omada Health | Initiates: Equal-Weight | $17 | $16.12 | +5.46% | 1 | Jan 9, 2026 | |
| OMCL Omnicell | Maintains: Overweight | $43 → $52 | $50.52 | +2.93% | 18 | Jan 5, 2026 | |
| VEEV Veeva Systems | Maintains: Overweight | $341 → $333 | $222.21 | +49.86% | 9 | Nov 25, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $6 → $5 | $2.31 | +116.45% | 7 | Nov 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $12 → $9 | $4.71 | +91.08% | 5 | Nov 5, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $62 → $65 | $41.26 | +57.54% | 12 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $10 → $8 | $6.28 | +27.39% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $7 | $2.68 | +161.19% | 8 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $125 | $85.37 | +46.42% | 9 | Feb 26, 2025 |
Phreesia
Jan 9, 2026
Initiates: Overweight
Price Target: $30
Current: $16.39
Upside: +83.04%
Hinge Health
Jan 9, 2026
Initiates: Overweight
Price Target: $68
Current: $43.33
Upside: +56.94%
Waystar Holding
Jan 9, 2026
Initiates: Overweight
Price Target: $41
Current: $30.27
Upside: +35.45%
Claritev
Jan 9, 2026
Initiates: Equal-Weight
Price Target: $33
Current: $30.44
Upside: +8.41%
Omada Health
Jan 9, 2026
Initiates: Equal-Weight
Price Target: $17
Current: $16.12
Upside: +5.46%
Omnicell
Jan 5, 2026
Maintains: Overweight
Price Target: $43 → $52
Current: $50.52
Upside: +2.93%
Veeva Systems
Nov 25, 2025
Maintains: Overweight
Price Target: $341 → $333
Current: $222.21
Upside: +49.86%
Health Catalyst
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.31
Upside: +116.45%
American Well
Nov 5, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $4.71
Upside: +91.08%
Doximity
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $62 → $65
Current: $41.26
Upside: +57.54%
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $6.28
Upside: +27.39%
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $2.68
Upside: +161.19%
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $85.37
Upside: +46.42%